| Up
2005P-0050:
ANDA SUITABILITY FOR COLISTIMETHATE SODIUM 150 MG/2 ML SOLUTION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 02/02/2005
|
| 02/02/2005
|
| Drug Industry
|
| Pharmaceutical Resources
Group Consulting
|
|
|
|
|
|
|
| pdf,
Attachments: 01,
02
|
|
|
|
|
| Signature:
|
| Michael J. Walters
|
|
|
|
|
| ACK1
|
| 02/02/2005
|
| 02/02/2005
|
| Federal
Government
|
| HFA-305
to Pharmaceutical Resources Group Consulting
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| Gloria Ortega
| |
Top | Up
Page last updated
February 17, 2005
kk |
